General

Bharat Biotech begins export

Author : NewsGram Desk

Bharat Biotech on Monday announced that it has commenced export of Covid-19 vaccine Covaxin.

Long Pending export orders have been executed during November, to be further expanded during the following months, the Hyderabad-based company said in a statement.

With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December, it said.

The vaccine maker thanked the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic, it added.

The company earlier said it was poised to achieve its goal of an annual capacity of about one billion doses of Covaxin by the end of 2021.

(IANS/JB)

Keywords: Bharat Biotech, Vaccines, Covaxin, India, Exports

Subscribe to our channels on YouTube and WhatsApp 

Sharjeel Imam Concludes Arguments In Delhi Riots Conspiracy Case, Denies Coordination With Umar Khalid

Union Budget 2026–27 Likely on February 1, FM Sitharaman to Present her Ninth Consecutive Budget

Uttar Pradesh Completes Most Extensive SIR Drive in an Indian State, Draft Voter List Revised to 12.55 Crore After 2.89 Crore Deletions

ED Raids I-PAC Office, Founder's Home Ahead of West Bengal Polls—Mamata Banerjee Alleges Targeting, Misuse of Central Agencies

FARA Filings Reveal: India Repeatedly Contacted US Gov on Day of Op Sindoor Ceasefire, Pakistan Sought Trump Intervention